{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:58:46Z","timestamp":1771657126019,"version":"3.50.1"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Thymoma is a type of rare tumor in the thymus gland, and among patients with thymoma, less than 10% will develop pure red cell aplasia (PRCA), whereas less than 5% of patients with PRCA have a thymoma. The optimal approach for PRCA in thymoma is immunosuppressive therapy, such as steroids, cyclosporine, and human antithymocyte globulin.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A sixty-one-year-old male was diagnosed with thymoma with PRCA after he complained fatigue, tinnitus, and weakness for 1 month, he received therapy with recombinant erythropoietin (rhEPO) for 1 month after the tumor was totally resected and readmitted with pulmonary embolism and received anticoagulation therapy with enoxaparin for 3 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Thymoma, pure red cell aplasia, pulmonary embolism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>He received cyclosporine A, prednisone and rhEPO treatment. Two months after the thymectomy and postoperative radiation, he was readmitted with pulmonary embolism.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Thymoma and pulmonary embolism become complete response (CR), PRCA become partial response (PR).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Clinicians should be alert to the possibility of the increased risk of thrombosis induced by rhEPO when it used to treat PRCA associated with thymoma. If other medication is effective for managing PRCA, rhEPO should be avoided.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000014789","type":"journal-article","created":{"date-parts":[[2019,3,10]],"date-time":"2019-03-10T12:11:06Z","timestamp":1552219866000},"page":"e14789","source":"Crossref","is-referenced-by-count":4,"title":["Occurrence of acute pulmonary embolism induced by recombinant erythropoietin during treatment of pure red cell aplasia associated with thymoma"],"prefix":"10.1097","volume":"98","author":[{"given":"Xiangli","family":"Cui","sequence":"first","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zirui","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhua","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230914","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.JTO.0000263705.23579.ee","article-title":"Pure red cell aplasia and thymoma","volume":"2","author":"Thompson","year":"2007","journal-title":"J Thorac Oncol"},{"key":"R2-20230914","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3324\/haematol.2017.175810","article-title":"Rational management approach to pure red cell aplasia","volume":"103","author":"Balasubramanian","year":"2018","journal-title":"Haematol"},{"key":"R3-20230914","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","article-title":"Pure red cell aplasia","volume":"128","author":"Robert","year":"2016","journal-title":"Blood"},{"key":"R4-20230914","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.biopha.2003.08.001","article-title":"Pure red cell aplasia\u2014a rare disease with multiple causes","volume":"57","author":"Djaldetti","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"R5-20230914","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2141.2006.06295.x","article-title":"Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience","volume":"135","author":"Thompson","year":"2006","journal-title":"Br J Haematol"},{"key":"R6-20230914","first-page":"1141","article-title":"Recombinant human erythropoietin and the risk of thrombosis in patients receiving thalidomide for multiple myeloma","volume":"89","author":"Galli","year":"2004","journal-title":"Haematologica"},{"key":"R7-20230914","first-page":"755","article-title":"Cyclosporin improved pure red cell aplasia associated with thymoma and tended to decrease thymoma size: a case report","volume":"41","author":"Mochizuki","year":"2003","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"R8-20230914","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1365-2141.2002.3317_3.x","article-title":"Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment","volume":"116","author":"Auner","year":"2002","journal-title":"Br J Haematol"},{"issue":"(6 suppl)","key":"R9-20230914","first-page":"ECR17","article-title":"Successful treatment of pure red cell aplasia with cyclosporin A and erythropoietin after thymectomy in a 88-year old woman","volume":"89","author":"Maeda","year":"2004","journal-title":"Haematologica"},{"key":"R10-20230914","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJMoa011931","article-title":"Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin","volume":"346","author":"Casadevall","year":"2002","journal-title":"N Engl J Med"},{"issue":"(suppl 1)","key":"R11-20230914","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1681\/ASN.2004110959","article-title":"Epoetin-induced autoimmune pure red cell aplasia","volume":"16","author":"Casadevall","year":"2005","journal-title":"J Ame Soci Neph"},{"issue":"(suppl 8)","key":"R12-20230914","doi-asserted-by":"crossref","first-page":"viii18","DOI":"10.1093\/ndt\/gfh1112","article-title":"Adverse event issue management: what have we learnt from pure red cell aplasia (PRCA)?","volume":"20","author":"Macdougall","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R13-20230914","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/asheducation-2006.1.348","article-title":"Thrombotic complications of malignancy","volume":"1","author":"Zonder","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R14-20230914","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.leukres.2008.04.006","article-title":"Pure red cell aplasia associated with thymoma: is thymectomy the cure?","volume":"33","author":"Bhargava","year":"2009","journal-title":"Leuk Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00005792-201903080-00061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T19:07:38Z","timestamp":1694718458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201903080-00061"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000014789","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}